The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia is a Strong Predictor for Survival

被引：0
|
作者：
Yilmaz, Musa [1 ]
Kantarjian, Hagop [1 ]
Wang, Xuemei [2 ]
Loghavi, Sanam [3 ]
Khoury, Joseph [3 ]
Jorgensen, Jeffrey [3 ]
Ravandi, Farhad [1 ]
Short, Nicholas [1 ]
Cortes, Jorge [1 ]
Garcia-Manero, Guillermo [1 ]
Kadia, Tapan [1 ]
Sasaki, Koji [1 ]
Konopleva, Marina [1 ]
Takahashi, Koichi [1 ]
Wierda, William [1 ]
Khouri, Maria [1 ]
Jain, Nitin [1 ]
Verstovsek, Srdan [1 ]
Estrov, Zeev [1 ]
Bose, Prithviraj [1 ]
Pierce, Sherry [1 ]
Garris, Rebecca [1 ]
O'Brien, Susan [4 ]
Jabbour, Elias [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
minimal residual disease; ALL; survival; early; acute lymphoblastic leukemia;
D O I：
10.1016/j.clml.2019.07.040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ALL-280
引用
收藏
页码：S193 / S194
页数：2
相关论文
共 50 条
  • [11] Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia
    Lu, Run-Qing
    Wu, Li-Xin
    Zhang, Jing
    Qin, Ya-Zhen
    Liu, Yan-Rong
    Lai, Yue-Yun
    Jiang, Hao
    Chang, Ying-Jun
    Ruan, Guo-Rui
    Huang, Xiao-Jun
    HEMATOLOGY, 2021, 26 (01) : 9 - 15
  • [12] Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic Leukemia
    Wolach, Ofir
    Stone, Richard M.
    CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4262 - 4269
  • [13] Immunophenotype of Measurable Residual Blast Cells as an Additional Prognostic Factor in Adults with B-Cell Acute Lymphoblastic Leukemia
    Davydova, Yulia
    Galtseva, Irina
    Kapranov, Nikolay
    Nikiforova, Ksenia
    Aleshina, Olga
    Chabaeva, Yulia
    Isinova, Galina
    Kotova, Ekaterina
    Sokolov, Andrey
    Troitskaya, Vera
    Kulikov, Sergey
    Parovichnikova, Elena
    DIAGNOSTICS, 2023, 13 (01)
  • [14] Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Zugmaier, Gerhard
    Dombret, Herve
    Stein, Anthony
    Bonifacio, Massimiliano
    Graux, Carlos
    Faul, Christoph
    Brueggemann, Monika
    Taylor, Kate
    Mergen, Noemi
    Reichle, Albrecht
    Horst, Heinz-August
    Havelange, Violaine
    Topp, Max S.
    Bargou, Ralf C.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2665 - 2673
  • [15] Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy
    Liu, Zhiyu
    Li, Yang
    Shi, Ce
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 337 - 343
  • [16] Differential Impact of Minimal Residual Disease Negativity According to the Salvage Status in Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Jabbour, Elias
    Short, Nicholas J.
    Jorgensen, Jeffrey L.
    Yilmaz, Musa
    Ravandi, Farhad
    Wang, Sa A.
    Thomas, Deborah A.
    Khoury, Joseph
    Champlin, Richard E.
    Khouri, Issa
    Kebriaei, Partow
    O'Brien, Susan M.
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Sasaki, Koji
    Dinardo, Courtney D.
    Kadia, Tapan M.
    Jain, Nitin
    Konopleva, Marina
    Garris, Rebecca
    Kantarjian, Hagop M.
    CANCER, 2017, 123 (02) : 294 - 302
  • [17] Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy
    Zhiyu Liu
    Yang Li
    Ce Shi
    International Journal of Hematology, 2021, 113 : 337 - 343
  • [18] The significance of peripheral blood minimal residual disease to predict early disease response in patients with B-cell acute lymphoblastic leukemia
    Setiadi, A.
    Owen, D.
    Tsang, A.
    Milner, R.
    Vercauteren, S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (05) : 527 - 534
  • [19] Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia
    Yana, Nan
    Wang, Zi-Long
    Wang, Xiao-Juan
    Gale, Robert Peter
    Zhou, Ya-Lan
    Zhao, Ming-Yue
    Wu, Li-Xin
    Liao, Ming-Yue
    Yang, Jie
    Wang, Chun-Yang
    Zhu, Jian-Hua
    Jiang, Hao
    Jiang, Qian
    Liu, Yan-Rong
    Chang, Ying-Jun
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Ma, Tong-Hui
    Huang, Xiao-Jun
    Ruan, Guo-Rui
    CANCER LETTERS, 2024, 598
  • [20] Clinical significance of end of induction measurable residual disease monitoring in B-cell acute lymphoblastic leukemia: A single center experience
    Arunachalam, Arun Kumar
    Selvarajan, Sushil
    Mani, Thenmozhi
    Janet, Nancy Beryl
    Maddali, Madhavi
    Lionel, Sharon Anbumalar
    Kulkarni, Uday
    Korula, Anu
    Aboobacker, Fouzia N.
    Abraham, Aby
    George, Biju
    Balasubramanian, Poonkuzhali
    Mathews, Vikram
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (06) : 440 - 452
12345